FOLH1 and prostate carcinoma: In a case study in a high-risk prostate carcinoma (Gleason score 9 (4 + 5), initial prostate specific antigen (PSA) level 7 ng/mL), Eder et al. [61] showed results of preoperative PET/CT imaging at one hour after intravenous administration of 68Ga-Glu-urea-Lys-(HE)3-HBED-CC-IRDye800CW (a derivative of 68Ga-PSMA-914) and subsequent RA fluorescence imaging (DaVinci Firefly camera) revealing strong tracer uptake of the primary tumor located in the left prostate lobe.